Market Insights Health Medical Technology Medical Devices

Diabetes Care Devices - Southern Europe

Southern Europe

Revenue in the Diabetes Care Devices market market in Southern Europe is projected to reach US$1.24bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 11.43%, resulting in a market volume of US$2.13bn by 2029.
In comparison to global figures, the majority of revenue will be generated the United States, which is expected to reach US$11,710.00m in 2024.
In Southern Europe, particularly in Italy, the demand for innovative diabetes care devices is rapidly increasing due to a growing emphasis on personalized healthcare solutions.

Key regions: Netherlands, Japan, France, Italy, China

Market

Region

Region comparison

Currency

Analyst Opinion

The Diabetes Care Devices Market in Southern Europe is witnessing considerable growth, fueled by an increase in diabetes prevalence, advancements in technology, and heightened awareness about diabetes management among patients and healthcare providers.

Customer preferences: Consumers in Southern Europe are increasingly prioritizing personalized diabetes management solutions, reflecting a shift towards individualized healthcare approaches. This trend is influenced by a growing awareness of the importance of tailored treatment plans, driven by cultural nuances that emphasize family support and community health. Additionally, the rise of mobile health applications is reshaping how patients engage with their diabetes care, enabling real-time monitoring and fostering a proactive approach to health management. As lifestyles evolve, there's a notable preference for devices that integrate seamlessly into daily routines, promoting convenience and consistency in diabetes care.

Trends in the market: In Southern Europe, the Diabetes Care Devices Market is experiencing a surge in demand for smart insulin delivery systems, as patients seek more efficient management of their condition. The adoption of continuous glucose monitoring (CGM) devices is also rising, reflecting a shift towards real-time data utilization for better health outcomes. Furthermore, there is an increasing integration of telehealth solutions, enabling remote consultations and support, which enhance accessibility for patients. These trends underscore the importance of innovation and customization in diabetes care, presenting significant opportunities for industry stakeholders to develop technologies that align with patient needs and preferences.

Local special circumstances: In Southern Europe, the Diabetes Care Devices Market is shaped by distinct cultural attitudes towards health and wellness, with a strong emphasis on quality of life and preventive care. The Mediterranean diet, known for its health benefits, influences patient choices and fosters a proactive approach to diabetes management. Additionally, regulatory frameworks in countries like Spain and Italy encourage the adoption of innovative technologies, facilitating quicker market entry for advanced devices. This combination of cultural values and supportive regulations creates a unique environment that drives the demand for personalized diabetes care solutions.

Underlying macroeconomic factors: The Diabetes Care Devices Market in Southern Europe is significantly influenced by macroeconomic factors, including the rising prevalence of diabetes and an aging population, which increase the demand for effective management solutions. National economic health, characterized by GDP growth and healthcare spending, supports investment in advanced medical technologies. Favorable fiscal policies and government initiatives promote innovation and accessibility in diabetes care. Furthermore, the integration of digital health solutions and remote monitoring technologies is bolstered by improved healthcare infrastructure, ensuring better patient outcomes and driving market expansion across the region.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.